Commentary: Accessibility of cancer drugs in Switzerland: Time from approval to pricing decision between 2009 and 2018 by Thomas Grischott

Connect to this object online.

Impact of the COVID-19 Pandemic on Elective and Emergency Inpatient Procedure Volumes in Switzerland - A Retrospective Study Based on Insurance Claims Data by Yael Rachamin, Matthias Meyer, Thomas Rosemann, Thomas Grischott

Connect to this object online.

Procedure Prioritization During a Nationwide Ban on Non-Urgent Healthcare: A Quasi-Experimental Retrospective Study of Hospital Data in Switzerland by Thomas Grischott, Tarun Mehra, Matthias R Meyer, Oliver Senn, Yael Rachamin

Connect to this object online.

Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice-A Cross-Sectional Database Study by Yael Rachamin, Levy Jäger, Rahel Meier, Thomas Grischott, Oliver Senn, Jakob M. Burgstaller, Stefan Markun

Connect to this object online.

The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females-Retrospective Study in 2018-2020 by Yael Rachamin, Yael Rachamin, Levy Jäger, Reka Schweighoffer, Andri Signorell, Caroline Bähler, Carola A. Huber, Carola A. Huber, Eva Blozik, Eva Blozik, Erich Seifritz, Thomas Grischott, Oliver Senn

Connect to this object online.